57 of 100 patients with atherosclerosis of lower extremities’ vessels and intermittent claudication have been randomized at two active investigative sites in Russia within the clinical trial managed by ARS clinical research team. The clinical study is sponsored by one of the leading manufacturers of generic parenteral antibiotics in India.